Combination of ciclopirox olamine and sphingosine-1-phosphate as granulation enhancer in diabetic wounds

Cocultures of Mesenchymal Stem Cells and Endothelial Cells As Organotypic Models of Prostate Cancer Metastasis

(2014) Mark S. K. Chong et al.   MOLECULAR PHARMACEUTICS

Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding

(2013) Ye Zeng et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

High-density lipoprotein of patients with Type 2 Diabetes Mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate

(2013) Xunliang Tong et al.   Cardiovascular Diabetology

Phase II angiogenesis stimulators

(2013) Domenico Ribatti et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Complementary effects of ciclopirox olamine, a prolyl hydroxylase inhibitor and sphingosine 1-phosphate on fibroblasts and endothelial cells in driving capillary sprouting

(2013) Sei Hien Lim et al.   Integrative Biology

Sphingosine-1-Phosphate as a Regulator of Hypoxia-Induced Factor-1α in Thyroid Follicular Carcinoma Cells

(2013) Veronica Kalhori et al.   PLoS One

Toward Repurposing Ciclopirox as an Antibiotic against Drug-Resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae

(2013) Kimberly M. Carlson-Banning et al.   PLoS One

A Paradigm of Fibroblast Activation and Dermal Wound Contraction to Guide the Development of Therapies for Chronic Wounds and Pathologic Scars

(2013) Howard Levinson   Advances in Wound Care

Splinting Strategies to Overcome Confounding Wound Contraction in Experimental Animal Models

(2013) Jeffrey M. Davidson et al.   Advances in Wound Care

Angiogenesis and scar formation in healing wounds

(2012) Luisa A. DiPietro   CURRENT OPINION IN RHEUMATOLOGY

Granulation Response and Partial Wound Closure Predict Healing in Clinical Trials on Advanced Diabetes Foot Ulcers Treated With Recombinant Human Epidermal Growth Factor

(2012) C. M. Valenzuela-Silva et al.   DIABETES CARE

Collagen Organization Critical Role in Wound Contraction

(2012) H. Paul Ehrlich et al.   Advances in Wound Care

Current Insights into the Role of HIF-1 in Cutaneous Wound Healing

(2011) E. Andrikopoulou et al.   CURRENT MOLECULAR MEDICINE

The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway

(2011) Y Luo et al.   ONCOGENE

Antimycotic Ciclopirox Olamine in the Diabetic Environment Promotes Angiogenesis and Enhances Wound Healing

(2011) Sae Hee Ko et al.   PLoS One

Zucker diabetic fatty rat: A new model of impaired cutaneous wound repair with type II diabetes mellitus and obesity

(2011) Rastislav Slavkovsky et al.   WOUND REPAIR AND REGENERATION

Activation of C-transactivation domain is essential for optimal HIF-1α-mediated transcriptional and angiogenic effects

(2008) Reshef Tal et al.   MICROVASCULAR RESEARCH

Endothelial-targeted Gene Transfer of Hypoxia-inducible Factor-1α Augments Ischemic Neovascularization Following Systemic Administration

(2008) Reshef Tal et al.   MOLECULAR THERAPY

Stabilization of HIF-1  is critical to improve wound healing in diabetic mice

(2008) I. R. Botusan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA